|
Delayed
NYSE
17:28:34 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.805 USD | -1.37% |
|
+18.75% | -79.47% |
| 08-20 | Top Premarket Decliners | MT |
| 08-13 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| MTNB | Delayed | |
CBOE
| MTNB | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 2.139 | 3.615 | 4.407 |
| Spread/Res. | -15.61% | -50.07% | -59.04% |
| Spread/Supp. | +18.75% | +18.75% | +6.14% |
| Support | 1.52 | 1.52 | 1.701 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MTNB Stock
- Charts Matinas BioPharma Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
